[1] Rhee SG.Inositol phospholipid-specific phospholipase C:interaction of the gamma 1 isoform with tyrosine kinase.Trends Biochem Sci, 1991, 16:297-301. [2] Cantley LC, Auger KR, Carpenter C, et al.Oncogenes and signal transduction.Cell, 1991, 64:281-302. [3] Ling LE, Druker BT, Cantley LC, et al.Transformation-defective mutants of polyomavirus middle T antigen associate with phosphatidylinositol 3-kinase (PI 3-kinase) but are unable to maintain wild-type levels of PI 3-kinase products in intact cells.J Virol, 1992, 66:1702-1708. [4] Shambrook J, Fritsch EF, Maniatis T, et al.Molecular Cloning-A Laboratory Manual.Cold Harbor Laboratory Press, 2nd,1989. [5] 张晓艳,马圣清,柳惠图.周期蛋白依赖激酶抑制因子在银屑病表皮中高表达.中华皮肤科杂志,1998,31:363-365. [6] 张晓艳,马圣清,柳惠图.蛋白激酶C在银屑病发病中的意义.中华皮肤科杂志,1999,32:74-76. [7] Ullrich A, Schlessinger J.Signal transduction by receptors with tyrosine kinase activity.Cell, 1990,61:203-212. [8] Bjorge JD, Chan TO, Antczak M, et al.Activated typeⅠ phosphatidylinositol kinase is associated with the epidermal growth factor(EGF) receptor following EGF stimulation.Proc Natl Acad Sci USA,1990,87:3816-3820. [9] Xu S, Cwyfan-Hughes SC, Van der Stappen JW, et al.Altered insulin-like growth factor-Ⅱ (IGF-Ⅱ) level and IGF-binding protein-3(IGFBP-3) protease activity in interstitial fluid taken from the skin lesion of psoriasis.J Invest Dermatol, 1996,106:109-112. |